In addition, circulating BAFF levels are increased in substantial fractions of patients with a variety of rheumatic disorders, including rheumatoid arthritis [28], [29], Sjögren's syndrome [25], [32], and progressive systemic sclerosis [33]. This evidence concerns the gene TNFSF13B and rheumatoid arthritis.